Graft-versus-host disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Graft-versus-host disease}}
{{Graft-versus-host disease}}
{{CMG}}
{{CMG}} {{shyam}}


==Overview==
==Overview==
 
The differential diagnosis of GvHD is broad given the complexity of post-transplant patients.


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 03:39, 16 June 2017

Graft-versus-host disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graft-versus-host disease differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graft-versus-host disease differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graft-versus-host disease differential diagnosis

CDC on Graft-versus-host disease differential diagnosis

Graft-versus-host disease differential diagnosis in the news

Blogs on Graft-versus-host disease differential diagnosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Graft-versus-host disease differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

The differential diagnosis of GvHD is broad given the complexity of post-transplant patients.

Differential Diagnosis

The differential diagnosis for GvHD can be categorized into the specific organs involved. When a post-transplant patient develops liver, GI, or skin symptoms, there are numerous possibilities regarding the etiology, as post-transplant patients are immunocompromised and at risk for infections. The clinical manifestations of infection in the liver, GI tract, and skin can mimic symptoms of GvHD.

For liver signs and symptoms, differential diagnosis includes:

For gastrointestinal signs and symptoms, differential diagnosis includes:

  • Typhilitis (neutropenic enterocolitis)
  • Clostridium difficile colitis
  • Viral gastroenteritis
  • Ischemic colitis

For skin signs and symptoms, differential diagnosis includes:

  • Varicella zoster (shingles)
  • Bacterial cellulitis
  • Fungal skin infection (tinea corporis)
  • Toxic erythema of chemotherapy

References

Template:WS Template:WH